Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_assertion type Assertion NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_head.
- NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_assertion wasGeneratedBy ECO_0000203 NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_provenance.
- NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_assertion wasDerivedFrom befree-2016 NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_provenance.
- NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_assertion SIO_000772 16458133 NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_provenance.
- NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_assertion evidence source_evidence_literature NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_provenance.
- NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_assertion description "[We studied the modifier effect of platelet antigen polymorphism (PlA2) on platelet inhibition by acetylsalicylic acid (ASA, i.e., aspirin), clopidogrel, or their combination in patients with coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534503.RAN4bFXdkf2e_BwWCFxoyUC8_EPncT9_GMZ1fD46fzbRg130_provenance.